• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (PRINGY) JUVEDERM VOLUMA XC 27G 2 X 1ML; IMPLANT, DERMAL, FOR AESTHETIC USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (PRINGY) JUVEDERM VOLUMA XC 27G 2 X 1ML; IMPLANT, DERMAL, FOR AESTHETIC USE Back to Search Results
Catalog Number 94640
Device Problem Improper or Incorrect Procedure or Method (2017)
Patient Problem Patient Problem/Medical Problem (2688)
Event Date 11/09/2016
Event Type  malfunction  
Manufacturer Narrative
Further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.Device labeling addresses the reported event(s) as follows: "precautions ¿ juvéderm voluma® xc is to be used as supplied.Modification or use of the product outside the directions for use may adversely impact the sterility, homogeneity, and performance of the product.".
 
Event Description
Healthcare professional reported that approximately 4 months after injection in the peri-orbital area and marionette lines with one syringe of juvéderm voluma® xc, the patient experienced a ¿possible granuloma, nodules and swelling.¿ the symptoms were in the area of injection as well as "a lot of the face." approximately 4.5 months after injection the patient was injected with hylenex.The patient was also treated with antibiotics, medrol dosepak, steroid injection, and an oral steroid.The patient also took some tetracycline which had not been prescribed.The juvéderm voluma® xc was diluted 1:1 with saline.A company healthcare professional noted that the physiological events are considered not device related given the injector reported the product was ¿diluted 1:1 with saline¿.Approximately 2 months after injection patient was injected to the lips with juvéderm volbella® xc but had no adverse events in that area.
 
Manufacturer Narrative
Device history record summary: the release step combined with the absence of any deviation shows that no element could explain these reactions: all the manufacturing steps and all the physicochemical and microbiological results (endotoxins, bioburden) are registered as conforming to the specifications.The sterilization cycle is registered as conforming.The extrusion force value shows an expected consistency of the product.
 
Event Description
Additional information: upon further follow up with healthcare professional, it was indicated that, ¿additional treatments with hylenex x 7¿ were provided an undetermined time after the initial treatment with hylenex.Kenalog was administered approximately 2 months after the first hylenex treatment.
 
Event Description
Further follow up with the healthcare professional revealed that symptoms resolved approximately 7 months after injection occurred.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
JUVEDERM VOLUMA XC 27G 2 X 1ML
Type of Device
IMPLANT, DERMAL, FOR AESTHETIC USE
Manufacturer (Section D)
ALLERGAN (PRINGY)
route de promery
zone artisanale de pre-mairy
pringy 74370
FR  74370
Manufacturer (Section G)
ALLERGAN (PRINGY)
route de promery
zone artisanale de pre-mairy
pringy 74370
FR   74370
Manufacturer Contact
suzanne wojcik
301 w howard lane
suite 100
austin, TX 78753
7372473605
MDR Report Key6559000
MDR Text Key74917160
Report Number3005113652-2017-00397
Device Sequence Number1
Product Code LMH
UDI-Device Identifier30888628000012
UDI-Public(01)30888628000012(10)VB20A60277(11)160624(17)171124
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P110033
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Nurse
Type of Report Initial,Followup,Followup
Report Date 07/05/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/10/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/24/2017
Device Catalogue Number94640
Device Lot NumberVB20A60277
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/14/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/24/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age45 YR
-
-